glp 1 drugs novo nordisk GoodRx, team to make GLP-1 meds affordable FDA asks for removal of
Description
We analyzed 756 636 singleton pregnancies among 480 231 women, with 529 pregnancies having periconceptional GLP-1 receptor agonist exposure
Zheng X, Xu F, Liang H, et al
The impact has been vast and further preclinical studies are still necessary to explore and understand the potential of the drugs that have already revolutionised the lives of millions of people with obesity and type 2 diabetes
At Listen Labs, we've talked to over 60 GLP-1 users and have 5,000 more ready to share their stories and test new products
Diabetes Care 28 (5), 10921100
